Aurora Cannabis Future Growth
Future criteria checks 1/6
Aurora Cannabis is forecast to grow earnings and revenue by 154.3% and 11.8% per annum respectively while EPS is expected to grow by 74.9% per annum.
Key information
154.3%
Earnings growth rate
74.9%
EPS growth rate
| Pharmaceuticals earnings growth | 23.9% |
| Revenue growth rate | 11.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
Aurora Cannabis: Revving Up To Profitability
Aug 08Aurora launches new cannabis products for adult and medical-use
Oct 17Aurora Cannabis further strengthens its balance sheet by repurchasing ~US$23M of convertible notes
Oct 07Aurora Cannabis Q4 2022 Earnings Preview
Sep 19Aurora Cannabis: Don't Let Your Money Go Up In Smoke
Aug 25Why Did Aurora Cannabis Stock Crash In May; Can It Recover?
Jun 13Recent Developments Do Not Change Our Stance On Aurora Cannabis
May 13Aurora Cannabis: A Train Wreck Desperate For Help
May 05Aurora Cannabis: The Fallen Pot Giant That Still Can't Find Its Way
Feb 17Aurora Cannabis Vs. HEXO: Which Is The Better Cannabis Stock?
Dec 17Tilray Vs. Aurora Cannabis: How To Compare These Cannabis Stocks
Oct 11Aurora Cannabis: Investors Should Have No Confidence In This Company
Sep 28Is Aurora Cannabis Stock A Buy Or Sell Before Upcoming Earnings? Buy The U.S. Opportunity
Sep 16Aurora Cannabis Is A Pass For Now, Although We Are Bullish On The Industry
Jun 05Aurora Cannabis: Extreme Downside Case Averted
Feb 02Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 392 | N/A | N/A | N/A | 1 |
| 3/31/2026 | 360 | 8 | 15 | 40 | 3 |
| 3/31/2025 | 329 | -9 | -3 | -14 | 5 |
| 9/30/2024 | 297 | -30 | -61 | -43 | N/A |
| 6/30/2024 | 279 | -30 | -67 | -49 | N/A |
| 3/31/2024 | 270 | -55 | -85 | -69 | N/A |
| 12/31/2023 | 266 | -116 | -91 | -71 | N/A |
| 9/30/2023 | 262 | -153 | -145 | -127 | N/A |
| 6/30/2023 | 248 | -195 | -141 | -127 | N/A |
| 3/31/2023 | 224 | -793 | -163 | -142 | N/A |
| 12/31/2022 | 212 | -1,748 | -181 | -157 | N/A |
| 9/30/2022 | 210 | -1,757 | -152 | -118 | N/A |
| 6/30/2022 | 221 | -1,718 | -142 | -110 | N/A |
| 3/31/2022 | 226 | -1,233 | -98 | -64 | N/A |
| 12/31/2021 | 231 | -381 | -122 | -82 | N/A |
| 9/30/2021 | 238 | -607 | -165 | -124 | N/A |
| 6/30/2021 | 245 | -692 | -264 | -211 | N/A |
| 3/31/2021 | 257 | -2,387 | -357 | -284 | N/A |
| 12/31/2020 | 275 | -2,359 | -430 | -285 | N/A |
| 9/30/2020 | 263 | -3,342 | -614 | -357 | N/A |
| 6/30/2020 | 269 | -3,231 | -691 | -342 | N/A |
| 3/31/2020 | 299 | -1,405 | -778 | -293 | N/A |
| 12/31/2019 | 291 | -1,430 | -787 | -289 | N/A |
| 9/30/2019 | 290 | -385 | -667 | -218 | N/A |
| 6/30/2019 | 246 | -294 | -606 | -192 | N/A |
| 3/31/2019 | 168 | -211 | -519 | -233 | N/A |
| 12/31/2018 | 119 | -72 | -439 | -206 | N/A |
| 9/30/2018 | 77 | 174 | -334 | -146 | N/A |
| 6/30/2018 | 55 | 72 | N/A | -82 | N/A |
| 3/31/2018 | 42 | -13 | N/A | -35 | N/A |
| 12/31/2017 | 31 | 7 | N/A | -16 | N/A |
| 9/30/2017 | 23 | -4 | N/A | -15 | N/A |
| 6/30/2017 | 18 | -13 | N/A | -13 | N/A |
| 3/31/2017 | 13 | -16 | N/A | -17 | N/A |
| 12/31/2016 | 8 | -13 | N/A | -11 | N/A |
| 9/30/2016 | 5 | -10 | N/A | -9 | N/A |
| 6/30/2016 | 1 | -6 | N/A | -7 | N/A |
| 3/31/2016 | 0 | 0 | N/A | -5 | N/A |
| 12/31/2015 | N/A | -3 | N/A | -3 | N/A |
| 9/30/2015 | N/A | -10 | N/A | -3 | N/A |
| 6/30/2015 | N/A | -10 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ACB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ACB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ACB's revenue (11.8% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: ACB's revenue (11.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ACB's Return on Equity is forecast to be high in 3 years time